Finally, in the multivariate analysis, we have shown that serum VEGF levels were a determinant of sPAP, suggesting a possible role for VEGF in the pathogenesis of PAH in patients with SSc. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.